Bio-Rad Launches External Quality Assurance Services Specialty Immunoassay Program
The External Quality Assurance Services Specialty Immunoassay program offers a external quality assessment for 13 key immunoassay analytes.
Read MorePosted by Andy Lundin | Oct 18, 2024 | Quality Control Programs |
The External Quality Assurance Services Specialty Immunoassay program offers a external quality assessment for 13 key immunoassay analytes.
Read MorePosted by Andy Lundin | Oct 18, 2024 | Cardiovascular, Molecular Diagnostics |
AMPEL BioSolutions’ new CardioGENE blood test predicts heart disease by identifying genetic markers and inflammatory pathways.
Read MorePosted by Andy Lundin | Oct 16, 2024 | Diagnostic Technologies |
Scientists are developing next-gen ophthalmoscopes with AI integration to detect early signs of diseases through non-invasive eye scans.
Read MorePosted by Chris Wolski | Sep 19, 2024 | Allergy & Autoimmune |
Thermo Fisher’s Phadia Laboratory Systems enhance the precision and speed of diagnosing autoimmune diseases, such as rheumatoid arthritis.
Read MorePosted by Andy Lundin | Sep 18, 2024 | Diabetes & Metabolic Diseases |
A new study encourages the use of more reliable tests to prevent pregnancy complications and the development of type II diabetes.
Read More